US lawmakers discuss stem cell research

March 8, 2006 01:32


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


US lawmakers debated embryonic stem cell research Tuesday in the aftermath of fabricated experiments in South Korea. Rep. Mark Souder, Republican chairman of the House of Representatives Government Reform subcommittee on criminal justice and drug policy, said he was disturbed by reports that women in South Korea were paid to donate their eggs for the fraudulent research. He said no human clinical trials or therapeutic applications using human embryonic stem cells currently exist. Rep. Elijah Cummings, a Democrat, said that "opponents of embryonic stem cell research seem to have difficulty containing their glee" over the case of disgraced cloning researcher Hwang Woo-suk, who is now under investigation for fraudulent claims of human stem cell breakthroughs. Cummings said instead of using the controversy as "a justification to impede the search for important new knowledge," lawmakers ensure that future research in America and elsewhere has strict government guidelines and oversight. Dr. James Battey, chairman of the National Institutes of Health stem cell task force, said that while the South Korean fraud was unacceptable, "it does not reflect on the potential of human embryonic stem cell research one way or the other."

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Auckland harbor
July 16, 2019
New Zealand lawmaker says Jesus’ mom was ‘Palestinian refugee’


Cookie Settings